Tove Wästerlid (T Wästerlid)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Venues

British journal of haematology

EJHaem

American journal of hematology

Blood cancer journal

Karolinska Universitetssjukhuset

Karolinska Institutet (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Karolinska Universitetssjukhuset Sep 01 2017

Sweden

Resident :: Department of Hematology

Education History

Karolinska Institutet Aug 31 2017

Sweden

PHD :: Department of Clinical Epidemiology

Lund University Medical Faculty Mar 01 2013 - Nov 18 2016

Sweden

PHD :: Clinical Medicine

Publications

Tove Wästerlid, Caroline E Weibull, Anna Oksanen, Linn Deleskog Spångberg, Björn Engelbrekt Wahlin, Gunilla Enblad, Per-Ola Andersson, Eva Kimby, Karin E Smedby
Treatment sequencing and impact of number of treatment lines on survival in follicular lymphoma: A national population-based study. EJHaem 5 (3) (2024)
Tove Wästerlid, Caroline E Weibull, Anna Oksanen, Linn Deleskog Spångberg, Björn Engelbrekt Wahlin, Gunilla Enblad, Per-Ola Andersson, Eva Kimby, Karin E Smedby
Treatment sequencing and impact of number of treatment lines on survival in follicular lymphoma: A national population-based study. EJHaem 5 (3) (2024)
Joachim Bæch, Simon Husby, Trine Trab, Kristian Kragholm, Peter Brown, Jette S Gørløv, Judit M Jørgensen, Sif Gudbrandsdottir, Marianne Tang Severinsen, Kirsten Grønbaek, Thomas Stauffer Larsen, Tove Wästerlid, Sandra Eloranta, Knut B Smeland, Lasse Hjort Kyneb Jakobsen, Tarec Christoffer El-Galaly
Cardiovascular diseases after high-dose chemotherapy and autologous stem cell transplant for lymphoma: A Danish population-based study. British journal of haematology 204 (3) (2023)
Joachim Bæch, Simon Husby, Trine Trab, Kristian Kragholm, Peter Brown, Jette S Gørløv, Judit M Jørgensen, Sif Gudbrandsdottir, Marianne Tang Severinsen, Kirsten Grønbaek, Thomas Stauffer Larsen, Tove Wästerlid, Sandra Eloranta, Knut B Smeland, Lasse Hjort Kyneb Jakobsen, Tarec Christoffer El-Galaly
Cardiovascular diseases after high-dose chemotherapy and autologous stem cell transplant for lymphoma: A Danish population-based study. British journal of haematology (2023)
Joachim Bæch, Simon Husby, Trine Trab, Kristian Kragholm, Peter Brown, Jette S Gørløv, Judit M Jørgensen, Sif Gudbrandsdottir, Marianne Tang Severinsen, Kirsten Grønbaek, Thomas Stauffer Larsen, Tove Wästerlid, Sandra Eloranta, Knut B Smeland, Lasse Hjort Kyneb Jakobsen, Tarec Christoffer El-Galaly
Cardiovascular diseases after high-dose chemotherapy and autologous stem cell transplant for lymphoma: A Danish population-based study. British journal of haematology 204 (3) (2023)
Cecilia Radkiewicz, Johanna B Bruchfeld, Caroline E Weibull, Tarec Christoffer El-Galaly, Henrik Frederiksen, Mats Lambe, Lasse Hjort Kyneb Jakobsen, Tarec C El-Galaly, Karin E Smedby, Tove Wästerlid
Sex differences in lymphoma incidence and mortality by subtype: A population-based study. American journal of hematology (2022)
Jóel Kristinn Jóelsson, Tove Wästerlid, Richard Rosenquist, Lasse Hjort Jakobsen, Tarec Christoffer El-Galaly, Karin E Smedby, Sandra Eloranta
Incidence and time trends of second primary malignancies after non-Hodgkin lymphoma: a Swedish population-based study. Blood advances 6 (8) (2022)
Jeanette Lundin, Tom A Mulder, Magdalena Kättström, Tove Wästerlid, Anders Uddevik, Håkan Mellstedt, Kia Heimersson, Lotta Hansson, Marzia Palma, Anders Österborg
Temporary cessation of ibrutinib results in reduced grade 3-4 infections and durable remissions-Interim analysis of an on-off-repeat Phase 1b/2 study in patients with chronic lymphocytic leukemia. EJHaem 2 (3) (2021)
Elsa Brånvall, Sara Ekberg, Sandra Eloranta, Tove Wästerlid, Brenda M Birmann, Karin E Smedby
Statin use and survival in 16 098 patients with non-Hodgkin lymphoma or chronic lymphocytic leukaemia treated in the rituximab era. British journal of haematology 195 (4) (2021)
Tove Wästerlid, Sverker Hasselblom, Jóel Kristinn Jóelsson, Caroline E Weibull, Georgios Rassidakis, Birgitta Sander, Karin E Smedby
Real-world data on treatment and outcomes of patients with primary mediastinal large B-cell lymphoma: a Swedish lymphoma register study. Blood cancer journal 11 (5) (2021)
Kristina Sonnevi, Maria Ljungqvist, Jóel Kristinn Jóelsson, Sara Harrysson, Tove Wästerlid, Per Bernell, Björn Engelbrekt Wahlin
Excellent survival after R-Hyper-CVAD in hospitalized patients with high-risk large B-cell lymphoma: The Karolinska experience. EJHaem 2 (4) (2021)
Elsa Brånvall, Sara Ekberg, Sandra Eloranta, Tove Wästerlid, Brenda M Birmann, Karin E Smedby
Statin use is associated with improved survival in multiple myeloma: A Swedish population-based study of 4315 patients. American journal of hematology 95 (6) (2020)
Tove Wästerlid, Kim Oren Gradel, Sandra Eloranta, Ingrid Glimelius, Tarec C El-Galaly, Henrik Frederiksen, Karin E Smedby
Clinical characteristics and outcomes among 2347 patients aged ≥85 years with major lymphoma subtypes: a Nordic Lymphoma Group study. British journal of haematology 192 (3) (2020)
Tove Wästerlid, Sara Harrysson, Therese M-L Andersson, Sara Ekberg, Gunilla Enblad, Per-Ola Andersson, Mats Jerkeman, Sandra Eloranta, Karin E Smedby
Outcome and determinants of failure to complete primary R-CHOP treatment for reasons other than non-response among patients with diffuse large B-cell lymphoma. American journal of hematology 95 (7) (2020)
Tove Wästerlid, M Mohammadi, Karin E Smedby, Ingrid Glimelius, Mats Jerkeman, M Bottai, S Eloranta
Impact of comorbidity on disease characteristics, treatment intent and outcome in diffuse large B-cell lymphoma: a Swedish lymphoma register study. Journal of internal medicine 285 (4) (2018)

Tove Wästerlid.css-eqlu8i{font-size:small;padding-left:4px;} (T Wästerlid)

Publication Activity (10 Years)

Top Topics

Top Venues

Tove Wästerlid (T Wästerlid)